MyAverix Finance
F · Healthcare
Glycorex Transplantation AB (publ) (O33)
Biotechnology
Glycorex Transplantation AB (publ) (O33) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $8.24M, P/E ratio is 18.00, net margin is -19.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for O33
Glycorex Transplantation AB (publ) (O33) — FAQ
What is Glycorex Transplantation AB (publ)'s market cap?
Glycorex Transplantation AB (publ) (O33) has a reported market cap of $8.24M (data as of 2026-03-30).
What is O33's P/E ratio?
The price-to-earnings (P/E) ratio for Glycorex Transplantation AB (publ) (O33) is 18.00 (data as of 2026-03-30).
Does Glycorex Transplantation AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Glycorex Transplantation AB (publ) (O33). Check the MyAverix Finance app for the latest dividend data.
What sector is Glycorex Transplantation AB (publ) in?
Glycorex Transplantation AB (publ) (O33) is classified in the Healthcare sector (Biotechnology industry).
What exchange is O33 listed on?
O33 is listed on F.
What is Glycorex Transplantation AB (publ)'s net margin?
Glycorex Transplantation AB (publ) (O33) reports a net margin of -19.8% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.